hotspot -WSS

hotspot

author：comprehensive 2025-09-27 13:11:06 - browse：165

Illustration of a red heart. -- health coverage from STAT — Adobe

Novo Nordisk’s obesity drug Wegovy cut the risk of major heart complications by 20% in a closely watched trial, results that could streamline insurance coverage and spur even greater demand for the highly popular therapy.

The milestone Select trial of about 17,500 patients is the first to show that an obesity medication leads to long-term cardiovascular benefits. The company reported only the topline figure in a press release Tuesday, and did not break out the reductions it said were seen in heart attacks, strokes, and cardiovascular deaths — the combined components of the study’s primary outcome. It said all three contributed to the decrease in cardiovascular events in the group that received Wegovy compared with participants given a placebo.

The 20% reduction was greater than many observers were expecting. In a research note Tuesday, Jefferies analysts called the results a “best case” outcome. “If they play baseball in Denmark,” Barclays analyst Emily Field wrote in a note, “Wegovy just hit a home run.”

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Wildfire smoke exposes gaps in outdoor worker protections
Next article： Removing probiotics from the NICU could threaten preemies' health

entertainment

WSS

The new shift in health care is toward less care

Shkreli is convicted of fraud. Can pharma finally slam the door on him?

Will General Catalyst be the first of many hospital takeovers?

The Sacklers, horror, and ‘The Fall of the House of Usher’

More doctors should go into startup world

Drastic changes should bring profitability, startup health insurers say

explore

hotspot

focus

How to save PrEP access — and even expand it

Man killed during FBI raid in connection with threats against Biden, other officials

Supreme Court strikes down use of affirmative action

Wegovy’s successful heart trial raises vital question about weight loss

Novavax promises a turnaround & Lilly roils the obesity market

Medicare solvency divides Republicans at the presidential debate

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

FDA panel issues narrow recommendation for Covid vaccine booster doses

Cancer drug shortages should be causing more outrage

Free speech concerns arise in wake of journal editor Eisen's firing

focus

Jack Smith previously got search warrant for Trump's Twitter, new court docs show

Medicare solvency divides Republicans at the presidential debate

Q&A: Figuring out how songbirds sing may lead to better understanding of how humans learn

Wayne Brady comes out as pansexual: 'Free to love whomever I want'

Wegovy’s successful heart trial raises vital question about weight loss

Police still searching for prisoner who escaped from NYC hospital

entertainment

entertainment

entertainment

leisure time